Cobra Biologics and Watson-Marlow Fluid Technology Group discuss the challenges of vaccine production

Hear from Cobra Biologics’ Technical Director, Tony Hitchcock, and from Watson-Marlow Fluid Technology Group’s (WMFTG) Peter Birch and Dr Sade Mokuolu, as they discuss the strategies for vaccine production, whilst maintaining critical quality standards.

This session discusses:

• The vaccines research landscape
• Learnings from previous epidemics including Ebola, SARS and MERS
• Progress made so far in the COVID-19 pandemic
• The challenges of vaccine development including the skills, technology and resources needed
• A particular focus on the challenges of scaling up production for a global pandemic

Download the whitepaper >>

View the webinar >>